« Back to Record
Citation APA

Merkel, P. P., Nair, P., Khalidi, N., Terrier, B., Hellmich, B., Bourdin, A., Jayne, D. R., Jackson, D. J., Roufosse, F., Pagnoux, C., Specks, U., Börjesson Sjö, L., Ho, C. C., Jison, M., McCrae, C., Necander, S., Rodríguez-Suárez, E., Shavit, A., Walton, C., & Wechsler, M. M. (2025). Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis. Annals of the Rheumatic Diseases. doi:10.1016/j.ard.2025.06.2131


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/393756

Merkel, P. P., Nair, P., Khalidi, N., Terrier, B., Hellmich, B., Bourdin, A., Jayne, D. R., Jackson, D. J., Roufosse, F., Pagnoux, C., Specks, U., Börjesson Sjö, L., Ho, C. C., Jison, M., McCrae, C., Necander, S., Rodríguez-Suárez, E., Shavit, A., Walton, C., & Wechsler, M. M. (2025). Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis. Annals of the Rheumatic Diseases. doi:10.1016/j.ard.2025.06.2131